A fibroblast activation protein (FAP) inhibitor labeled with gallium 68 (68Ga) (FAPI) PET is based on FAP’s molecular targeting, which is known to be highly expressed in cancer-associated fibroblasts, the main cell type in the tumor stroma. Here, FAP is linked to neoplasm.